Inventor
GUO LIANGQIN
US31 patents
⚠️ This page may combine multiple inventors who share the name “GUO LIANGQIN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
MERCK SHARP & DOHME
13 patentsUS10519147B2Dec 31, 2019
Diamino-alkylamino-linked arylsulfonamide compounds with selective activity in voltage-gated sodium channels
MERCK SHARP & DOHME1 citations61
US10221167B2Mar 5, 2019
Hydroxyalkylamine- and hydroxycycloalkylamine-substituted diamine-arylsulfonamide compounds with selective activity in voltage-gated sodium channels
MERCK SHARP & DOHME1 citations61
US11478461B2Oct 25, 2022
[1.1.1] bicyclo compounds as indoleamine 2,3-dioxygenase inhibitors
MERCK SHARP & DOHME0 citations51
US11352320B2Jun 7, 2022
Substituted [1.1.1] bicyclo compounds as indoleamine 2,3-dioxygenase inhibitors
MERCK SHARP & DOHME0 citations51
US11034661B2Jun 15, 2021
Substituted N′-hydroxycarbamimidoyl-1,2,5-oxadiazole compounds as indoleamine 2,3-dioxygenase IDO inhibitors
MERCK SHARP & DOHME0 citations51
US10988487B2Apr 27, 2021
Substituted n′-hydroxycarbamimidoyl-1,2,5-oxadiazole compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors
MERCK SHARP & DOHME0 citations51
US10968210B2Apr 6, 2021
Diamino-alkylamino-linked arylsulfonamide compounds with selective activity in voltage-gated sodium channels
MERCK SHARP & DOHME0 citations51
US10927086B2Feb 23, 2021
Substituted sulfoximine compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors
MERCK SHARP & DOHME0 citations51
US7652024B2Jan 26, 2010
Acylated spiropiperidine derivatives as melanocortin-4 receptor modulators
MERCK SHARP & DOHME2 citations47
US10538497B2Jan 21, 2020
Compounds as indoleamine 2,3-dioxygenase inhibitors
MERCK SHARP & DOHME0 citations40
US10189819B2Jan 29, 2019
Factor IXa inhibitors
MERCK SHARP & DOHME0 citations38
US9708308B2Jul 18, 2017
Factor IXa inhibitors
MERCK SHARP & DOHME0 citations38
US9914727B2Mar 13, 2018
Factor IXa inhibitors
MERCK SHARP & DOHME0 citations36
MERCK & CO INC
8 patentsUS6063796AMay 16, 2000
Somatostatin agonists
MERCK & CO INC38 citations92
US6025372AFeb 15, 2000
Somatostatin agonists
MERCK & CO INC45 citations92
US6458790B2Oct 1, 2002
Substituted piperidines as melanocortin receptor agonists
MERCK & CO INC56 citations90
US7276520B2Oct 2, 2007
Bicyclic piperidine derivatives as melanocortin-4 receptor agonists
MERCK & CO INC8 citations73
US6387932B1May 14, 2002
Somatostatin agonists
MERCK & CO INC7 citations59
US7329673B2Feb 12, 2008
Acylated spiropiperidine derivatives as melanocortin-4 receptor agonists
MERCK & CO INC2 citations51
US7160886B2Jan 9, 2007
Acylated piperazine derivatives as melanocortin-4 receptor agonists
MERCK & CO INC1 citations50
US7115628B2Oct 3, 2006
Bridged piperidine derivatives as melanocortin receptor agonists
MERCK & CO INC0 citations40
MERCK SHARP & DOHME LLC
8 patentsUS12152019B2Nov 26, 2024
Arylalkyl pyrazole compounds as indoleamine 2,3-dioxygenase inhibitors
MERCK SHARP & DOHME LLC2 citations72
US12091405B2Sep 17, 2024
Substituted pyrazole compounds as indoleamine 2,3-dioxygenase inhibitors
MERCK SHARP & DOHME LLC2 citations72
US11484565B2Nov 1, 2022
PCSK9 antagonist compounds
MERCK SHARP & DOHME LLC3 citations72
US12178842B2Dec 31, 2024
PCSK9 antagonist compounds
MERCK SHARP & DOHME LLC0 citations61
US12576087B2Mar 17, 2026
Aryloxypiperidine pyrazole compounds as indoleamine 2,3-dioxygenase inhibitors
MERCK SHARP & DOHME LLC0 citations51
US12264134B2Apr 1, 2025
Substituted piperazine amide compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors
MERCK SHARP & DOHME LLC0 citations51
US12246008B2Mar 11, 2025
4-amino or 4-alkoxy-substituted aryl sulfonamide compounds with selective activity in voltage-gated sodium channels
MERCK SHARP & DOHME LLC0 citations51
US12065438B2Aug 20, 2024
Substituted tricyclic compounds as indoleamine 2,3-dioxygenase inhibitors
MERCK SHARP & DOHME LLC0 citations51